Ablation Systems

This channel provides technology news on new ablation system advances in cardiac electrophysiology (EP) used to treat dysfunctional heart tissue that cause arrhythmias. Each cell in the myocardium generates its own electrical impulses to cause the heart to beat, but if some cells generate signals that are not in synch with other parts of the heart, it causes an arrhythmia, an abnormal heart beat. Ablation systems use heat (usually generated  by radio frequency, RF, energy or a laser) or extreme cold to cause small burns. These lesions create scar tissue that block electrical signals causing the arrhythmia. These procedures are guided by EP electro mapping systems

News | EP Lab

January 14, 2022 — Medtronic has entered into a definitive agreement to acquire Affera Inc., a Boston area-based ...

Home January 14, 2022
Home
News | EP Lab

January 13, 2022 — Abbott received U.S. Food and Drug Administration (FDA) clearance for the EnSite X EP System with ...

Home January 13, 2022
Home
News | EP Lab

January 7, 2022 — Khaldoun Tarakji, M.D., M.P.H., associate section head of cardiac electrophysiology at the Heart ...

Home January 07, 2022
Home
News | EP Lab

January 5, 2022 — Stereotaxis announced a recent publication in Frontiers in Cardiovascular Medicine titled “Atrial ...

Home January 05, 2022
Home
Videos | EP Lab

Christine Albert, M.D., MPH, professor, chair of the Department of Cardiology and the Lee and Harold Kapelovitz ...

Home November 22, 2021
Home
News | EP Lab

November 16, 2021 — Acutus Medical Inc. (Acutus), an arrhythmia management company focused on improving the way cardiac ...

Home November 16, 2021
Home
News | EP Lab

October 28, 2021 — CathVision, a medical technology company developing electrophysiology (EP) solutions in EP recording ...

Home October 28, 2021
Home
Videos | EP Mapping and Imaging Systems

An example of the Acutus Medical AcQMap High Resolution Imaging and Mapping System to guide electrophysiology (EP) cardi ...

Home October 14, 2021
Home
News | EP Lab

October 6, 2021 – Biosense Webster announced the first cases using a radiofrequency balloon ablation catheter were ...

Home October 06, 2021
Home
Gadolinium-enhanced MRI of a cardiac radiation therapy patient at baseline (left) and 3 months post-treatment (right). Top: the left ventricle with patchy, gadolinium-enhanced scar was transmurally targeted with a radiation ose of 25 Gy between 3 and 6 o’clock (red brackets). Nonenhanced, remote myocardium is adjacent to target region (white arrowhead). Bottom: surviving nonenhanced myocardium within the same images is visible in the targeted region at baseline and 3 months post-treatment (yellow outline).
Feature | EP Lab

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Home September 28, 2021
Home
News | Atrial Fibrillation

September 28, 2021 — Image-guided fibrosis ablation in addition to pulmonary vein isolation (PVI) does not improve ...

Home September 28, 2021
Home
News | Atrial Fibrillation

September 13, 2021 — Ablation plus cardiac resynchronization therapy (CRT) is superior to pharmacological rate control ...

Home September 13, 2021
Home
News | EP Lab

September 1, 2021 — Stereotaxis and Shanghai Microport EP Medtech Co., Ltd. announced a broad collaboration to advance ...

Home September 01, 2021
Home
News | EP Lab

August 9, 2021 – Results from an international clinical trial show a significant reduction in risk of ventricular ...

Home August 09, 2021
Home
News | Atrial Fibrillation

August 9, 2021 — Adagio Medical Inc., a provider of catheter ablation technologies for atrial fibrillation (AF) and ...

Home August 09, 2021
Home
Subscribe Now